BioSpace News Archive

Policy

Lovelace Biomedical & Exemplar Genetics Win New Contract to Develop New Model of Sickle Cell Disease

Lovelace Biomedical and Exemplar Genetics have teamed together to win a contract from the National Institutes of Health’s National Center for the Advancement of Translational Sciences, for the study of Sickle Cell Disease.

July 11, 2019
·
1 min read
Drug Development

New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality® (galcanezumab-gnlm) in Episodic Cluster Headache

Eli Lilly and Company announced that the New England Journal of Medicine published positive Phase 3 study results of Emgality® for the treatment of episodic cluster headache.

July 11, 2019
·
8 min read
Deals

Nova to Report Second Quarter 2019 Financial Results on August 7, 2019

Nova, announced that it will release its results for the second quarter of 2019 before the Nasdaq market opens on Wednesday, August 7, 2019.

July 11, 2019
·
4 min read
Policy

Kraig Biocraft Laboratories awarded expanded investment license in Vietnam

Kraig Biocraft Laboratories, Inc., the leading developer of spider silk based fibers, announces that the Company has been awarded an increased investment license for expansion of its recombinant spider silk production at Prodigy Textiles, its Vietnamese subsidiary.

July 11, 2019
·
2 min read
Job Trends

Newly Published Study Establishes Evidence-Based Population for Clinical Use of DecisionDx-Melanoma in Patients With Thin Cutaneous Melanoma Tumors

Study published recently in SKIN: The Journal of Cutaneous Medicine

July 11, 2019
·
5 min read
Pharm Country

Biohaven Launches ‘Demand More’ Campaign At 2019 American Headache Society Annual Scientific Meeting: Highlighting Patient Needs In Acute Treatment Of Migraine

Research suggests patients define effective migraine therapies as reliable pain relief that enables them to return to their lives. Current treatments limit the ability for some patients to reach their treatment goals due to nonresponse to standard therapies and side effects.

July 11, 2019
·
6 min read
Business

eSimplify Announces the Addition of Hospital Executive Craig Saylor MA FACHE CPHQ to the Executive Board of Advisors

Craig’s experience will help guide the development and assure the marketability of all eSimplify solutions.

July 11, 2019
·
1 min read
Deals

AbbVie to Host Second-Quarter 2019 Earnings Conference Call

AbbVie, a research-based global biopharmaceutical company, will announce its second-quarter 2019 financial results on Friday, July 26 before the market opens.

July 11, 2019
·
1 min read
Pharm Country

Actinium Highlights Two Presentations at the Health Physics Society Annual Meeting Supporting the Safety Profile of Iomab-B for SIERRA Trial Caregivers

Studies observed minimal cumulative radiation exposure to clinical staff providing care to patients treated with Iomab-B in the SIERRA trial of 0.09 mSv, contributing minimal exposure to the 50 mSv annual occupational dose limit

July 11, 2019
·
8 min read
Job Trends

Novant Calls CortexDecoder For Epic Rover “Life Changing”

Code, an innovator in healthcare automation and mobile technology, is excited to recognize Novant Health’s commitment to improved mobile healthcare scanning with the implementation of Code’s scanning solution CortexDecoder for Epic Rover.

July 11, 2019
·
3 min read